General Information of Drug Transporter (DT)
DT ID DTD0496 Transporter Info
Gene Name SLC9B2
Transporter Name Sodium/hydrogen exchanger 9B2
Gene ID
133308
UniProt ID
Q86UD5
Post-Translational Modification of This DT
Overview of SLC9B2 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X-Ubiquitination X: Amino Acid

Phosphorylation

  Serine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9B2 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

49

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9B2 Serine 49 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9B2 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

46

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9B2 Threonine 46 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC9B2 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

62

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC9B2 Threonine 62 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC9B2 [5]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

36

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC9B2 Lysine 36 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC9B2 [5]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

38

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC9B2 Lysine 38 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC9B2 [5]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

53

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC9B2 Lysine 53 has the potential to affect its expression or activity.
References
1 UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
2 A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
3 CEP128 Localizes to the Subdistal Appendages of the Mother Centriole and Regulates TGF-beta/BMP Signaling at the Primary Cilium. Cell Rep. 2018 Mar 6;22(10):2584-2592.
4 Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
5 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.